DUPIXENT (dupilumab)
ECZEMA AGENTS SYSTEMIC INTERLEUKIN-4 (IL-4RA)ANTAG.MCAB·ATOPIC DERMATITIS·+10
Sanofi-Aventis U.S.
Indication
Allergic fungal rhinosinusitis
Allergic fungal rhinosinusitis is a distinct, noninvasive clinical subtype of chronic rhinosinusitis with nasal polyps driven by an intense type 2 hypersensitivity response to colonizing environmental fungi. Read more about Allergic fungal rhinosinusitis
3 drugs 1 manufacturers
Drugs that treat it
Common Allergic fungal rhinosinusitis therapies.
DUPIXENT PEN (dupilumab)
ECZEMA AGENTS SYSTEMIC INTERLEUKIN-4 (IL-4RA)ANTAG.MCAB·ATOPIC DERMATITIS·+10
Sanofi-Aventis U.S.
DUPIXENT SYRINGE (dupilumab)
ECZEMA AGENTS SYSTEMIC INTERLEUKIN-4 (IL-4RA)ANTAG.MCAB·ATOPIC DERMATITIS·+10
Sanofi-Aventis U.S.
Filter & compare in the drug finder →Opens the drug finder with Allergic fungal rhinosinusitis preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAllergic fungal rhinosinusitis is a distinct, noninvasive clinical subtype of chronic rhinosinusitis with nasal polyps driven by an intense type 2 hypersensitivity response to colonizing environmental fungi.
It primarily affects the sinonasal tract of immunocompetent, typically atopic adolescents and young adults.
Pathophysiologically and clinically, it is characterized by extensive bilateral or unilateral nasal polyposis, immunoglobulin E-mediated hypersensitivity, and the accumulation of thick, eosinophil-rich "allergic mucin" containing noninvasive fungal hyphae and Charcot-Leyden crystals.
Continued accumulation of this dense mucin frequently produces an expansile mass effect that can erode adjacent bony sinus walls and extend toward the orbit or skull base.
- nih.gov
Allergic fungal rhinosinusitis is a distinct, noninvasive clinical subtype of chronic rhinosinusitis with nasal polyps driven by an intense type 2 hypersensitivity response to colonizing environmental fungi It primarily affects the sinonasal tract of immunocompetent, typically atopic adolescents and young adults Pathophysiologically and clinically, it is characterized by extensive bilateral or unilateral nasal polyposis, immunoglobulin E-mediated hypersensitivity, and the accumulation of thick, ...
- nih.gov
Allergic fungal rhinosinusitis is a distinct, noninvasive clinical subtype of chronic rhinosinusitis with nasal polyps driven by an intense type 2 hypersensitivity response to colonizing environmental fungi Pathophysiologically and clinically, it is characterized by extensive bilateral or unilateral nasal polyposis, immunoglobulin E-mediated hypersensitivity, and the accumulation of thick, eosinophil-rich "allergic mucin" containing noninvasive fungal hyphae and Charcot-Leyden crystals
- nih.gov
Allergic fungal rhinosinusitis is a distinct, noninvasive clinical subtype of chronic rhinosinusitis with nasal polyps driven by an intense type 2 hypersensitivity response to colonizing environmental fungi Continued accumulation of this dense mucin frequently produces an expansile mass effect that can erode adjacent bony sinus walls and extend toward the orbit or skull base
- nih.gov
It primarily affects the sinonasal tract of immunocompetent, typically atopic adolescents and young adults
- mdpi.com
It primarily affects the sinonasal tract of immunocompetent, typically atopic adolescents and young adults
- nih.gov
Pathophysiologically and clinically, it is characterized by extensive bilateral or unilateral nasal polyposis, immunoglobulin E-mediated hypersensitivity, and the accumulation of thick, eosinophil-rich "allergic mucin" containing noninvasive fungal hyphae and Charcot-Leyden crystals Continued accumulation of this dense mucin frequently produces an expansile mass effect that can erode adjacent bony sinus walls and extend toward the orbit or skull base
Personalize your experience
Follow Allergic fungal rhinosinusitis and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.